Steward Partners Investment Advisory, LLC
Position in SCLX — Scilex Holding Co
CIK 1723397
STAMFORD, CT
Position in SCLX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$53
-$56 QoQ
Shares Held
8
-11.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Steward Partners Investment Advisory, LLC holds $457,189,468 across 19 Drug Manufacturers - General names. SCLX ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
629,201 | $153,801,892 | |
| 2 | ABBV |
AbbVie Inc.
|
436,916 | $95,024,860 | |
| 3 | LLY |
ELI LILLY & Co
|
91,946 | $84,569,172 | |
| 4 | MRK |
Merck & Co., Inc.
|
305,398 | $36,736,325 | |
| 5 | AMGN |
Amgen Inc
|
76,905 | $27,059,024 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
244,135 | $14,806,787 | |
| 7 | PFE |
Pfizer Inc
|
472,519 | $13,268,333 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
75,160 | $10,475,049 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53 | 8 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $109 | 9 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $177 | 9 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $53 | 9 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||